Fund Holdings — Avidity Partners Management LP

Total Portfolio Value:
$439.39M
Total Bought:
$222.27M
Total Sold:
$281.45M
Net Transaction:
-$59.18M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Dianthus Therapeutics, Inc.(DNTH)1,742,9023,204,184+1,461,282$32.47M$126.08M28.70%+$93.61M
CG Oncology, Inc.(CGON)1,499,9421,600,899+100,957$39.00M$64.48M14.68%+$25.49M
Medtronic plcSHS(MDT)0190,600+190,600$0$18.15M4.13%+$18.15M
Boston Scientific Corporation(BSX)321,800164,300-157,500$34.56M$16.04M3.65%-$18.52M
Oruka Therapeutics, Inc.(ORKA)352,124660,424+308,300$3.95M$12.70M2.89%+$8.75M
Bristol-Myers Squibb Company(BMY)0257,600+257,600$0$11.62M2.64%+$11.62M
Natera, Inc.(NTRA)199,30070,400-128,900$33.67M$11.33M2.58%-$22.34M
Danaher Corporation(DHR)89,70054,700-35,000$17.72M$10.84M2.47%-$6.87M
Teva Pharmaceutical Industries LimitedADS(TEVA)689,500510,000-179,500$11.56M$10.30M2.34%-$1.25M
Perspective Therapeutics, Inc.(CATX)1,858,5962,994,033+1,135,437$6.39M$10.27M2.34%+$3.88M
Jade Biosciences Inc1,127,1861,127,1860$11.26M$9.73M2.21%-$1.53M
Pfizer Inc.(PFE)0366,400+366,400$0$9.34M2.12%+$9.34M
Thermo Fisher Scientific Inc.(TMO)29,60018,900-10,700$12.00M$9.17M2.09%-$2.83M
Context Therapeutics Inc.(CNTX)7,477,2558,981,855+1,504,600$4.90M$8.70M1.98%+$3.80M
Genmab A/SADS(GMAB)650,000248,100-401,900$13.43M$7.61M1.73%-$5.82M
Metsera Inc0140,500+140,500$0$7.35M1.67%+$7.35M
UnitedHealth Group Incorporated(UNH)32,00017,800-14,200$9.98M$6.15M1.40%-$3.84M
Arvinas, Inc.(ARVN)243,162698,363+455,201$1.79M$5.95M1.35%+$4.16M
Cencora Inc32,80019,000-13,800$9.84M$5.94M1.35%-$3.90M
Encompass Health Corporation(EHC)74,00041,900-32,100$9.07M$5.32M1.21%-$3.75M
Johnson & Johnson(JNJ)026,800+26,800$0$4.97M1.13%+$4.97M
The Cigna Group(CI)016,600+16,600$0$4.78M1.09%+$4.78M
AbbVie Inc.(ABBV)019,800+19,800$0$4.58M1.04%+$4.58M
McKesson Corporation(MCK)13,5005,800-7,700$9.89M$4.48M1.02%-$5.41M
Carlsmed, Inc.(CARL)0321,912+321,912$0$4.31M0.98%+$4.31M
Kenvue Inc.(KVUE)0265,200+265,200$0$4.30M0.98%+$4.30M
Immunic, Inc.(IMUX)5,615,8114,699,411-916,400$3.92M$4.14M0.94%+$226.0K
Arcutis Biotherapeutics, Inc.(ARQT)268,000214,400-53,600$3.76M$4.04M0.92%+$284.1K
Endeavour Silver Corp.(EXK)355,00073,600-281,400$18.86M$4.03M0.92%-$14.84M
Phathom Pharmaceuticals, Inc.(PHAT)1,064,500306,000-758,500$10.21M$3.60M0.82%-$6.61M
Repligen Corporation(RGEN)106,50023,300-83,200$13.25M$3.11M0.71%-$10.13M
Acadia Pharmaceuticals Inc0144,000+144,000$0$3.07M0.70%+$3.07M
Ascendis Pharma A/SADR(ASND)014,500+14,500$0$2.88M0.66%+$2.88M
Enliven Therapeutics Inc11,300140,300+129,000$226.7K$2.87M0.65%+$2.65M
Beam Therapeutics Inc.(BEAM)409,400112,000-297,400$6.96M$2.72M0.62%-$4.25M
SCYNEXIS, Inc.(SCYX)1,228,9103,350,528+2,121,618$829.3K$2.58M0.59%+$1.75M
HealthEquity, Inc.(HQY)92,00025,300-66,700$9.64M$2.40M0.55%-$7.24M
Wave Life Sciences, Inc.SHS(WVE)0297,500+297,500$0$2.18M0.50%+$2.18M
Xenon Pharmaceuticals Inc.(XENE)107,89153,400-54,491$3.38M$2.14M0.49%-$1.23M
Akero Therapeutics Inc134,00040,500-93,500$7.15M$1.92M0.44%-$5.23M
Insmed Incorporated(INSM)59,00011,600-47,400$5.94M$1.67M0.38%-$4.27M
Karyopharm Therapeutics Inc.(KPTI)134,566134,5660$580.0K$880.1K0.20%+$300.1K
Immuneering CorpCL A090,900+90,900$0$636.3K0.14%+$636.3K
Altimmune, Inc.(ALT)105,0000-105,000$406.4K$0—-$406.4K
Apogee Therapeutics Inc65,0000-65,000$2.82M$0—-$2.82M
ARS Pharmaceuticals, Inc.(SPRY)140,0000-140,000$2.44M$0—-$2.44M
Axsome Therapeutics, Inc.(AXSM)94,5000-94,500$9.86M$0—-$9.86M
BridgeBio Pharma, Inc.(BBIO)140,0000-140,000$6.05M$0—-$6.05M
Cardinal Health, Inc.(CAH)15,0000-15,000$2.52M$0—-$2.52M
DexCom, Inc.(DXCM)210,5000-210,500$18.37M$0—-$18.37M
Doximity, Inc.CL A(DOCS)60,0000-60,000$3.68M$0—-$3.68M
Hinge Health, Inc.CL A(HNGE)322,3440-322,344$16.68M$0—-$16.68M
Humana Inc.(HUM)27,6000-27,600$6.75M$0—-$6.75M
Intellia Therapeutics, Inc.(NTLA)232,0000-232,000$2.18M$0—-$2.18M
Intuitive Surgical, Inc.(ISRG)27,1000-27,100$14.73M$0—-$14.73M
Kezar Life Sciences Inc
COM NEW
502,6000-502,600$2.30M$0—-$2.30M
Madrigal Pharmaceuticals, Inc.(MDGL)19,0000-19,000$5.75M$0—-$5.75M
MoonLake ImmunotherapeuticsA ORD(MLTX)39,0000-39,000$1.84M$0—-$1.84M
Omada Health, Inc.(OMDA)390,6000-390,600$7.15M$0—-$7.15M
Organon & Co.(OGN)640,0000-640,000$6.20M$0—-$6.20M
Reviva Pharmaceuticals Holding138,0000-138,000$52.6K$0—-$52.6K
Revolution Medicines, Inc.(RVMD)228,6000-228,600$8.41M$0—-$8.41M
Soleno Therapeutics Inc32,0000-32,000$2.68M$0—-$2.68M
Syndax Pharmaceuticals, Inc.(SNDX)150,0000-150,000$1.40M$0—-$1.40M
Tenet Healthcare Corporation(THC)106,0000-106,000$18.66M$0—-$18.66M
Ultragenyx Pharmaceutical Inc.(RARE)154,0000-154,000$5.60M$0—-$5.60M
uniQure N.V.SHS(QURE)207,0000-207,000$2.89M$0—-$2.89M
Verona Pharma PlcADS33,8000-33,800$3.20M$0—-$3.20M
Page 1 of 1
Avidity Partners Management LP — 13F Holdings — Q3 2025 | TickerTrail